These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11201523)

  • 1. Endothelium-dependent vasorelaxation in the aorta of transgenic mice expressing human apolipoprotein(a) or lipoprotein(a).
    Rubanyi GM; Freay AD; Lawn RM
    Endothelium; 2000; 7(4):253-64. PubMed ID: 11201523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)].
    Galle J; Winner B; Conzelmann E; Wanner C
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1035-45. PubMed ID: 9846885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic rabbits expressing human apolipoprotein (a).
    Fan J; Watanabe T
    J Atheroscler Thromb; 2000; 7(1):8-13. PubMed ID: 11425047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does lipoprotein(a) impair endothelial function?
    Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
    J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
    Linton MF; Farese RV; Chiesa G; Grass DS; Chin P; Hammer RE; Hobbs HH; Young SG
    J Clin Invest; 1993 Dec; 92(6):3029-37. PubMed ID: 8254057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
    Callow MJ; Verstuyft J; Tangirala R; Palinski W; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1639-46. PubMed ID: 7657833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamylated low-density lipoprotein induces endothelial dysfunction.
    Speer T; Owala FO; Holy EW; Zewinger S; Frenzel FL; Stähli BE; Razavi M; Triem S; Cvija H; Rohrer L; Seiler S; Heine GH; Jankowski V; Jankowski J; Camici GG; Akhmedov A; Fliser D; Lüscher TF; Tanner FC
    Eur Heart J; 2014 Nov; 35(43):3021-32. PubMed ID: 24658767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbits.
    Lebuffe G; Boullier A; Tailleux A; Delfly B; Dupuis B; Fruchart JC; Duverger N; Emmanuel F; Denefle P; Vallet B; Duriez P
    Biochem Biophys Res Commun; 1997 Dec; 241(1):205-11. PubMed ID: 9405258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial-Specific Overexpression of Histone Deacetylase 2 Protects Mice against Endothelial Dysfunction and Atherosclerosis.
    Hori D; Nomura Y; Nakano M; Han M; Bhatta A; Chen K; Akiyoshi K; Pandey D
    Cell Physiol Biochem; 2020 Sep; 54(5):947-958. PubMed ID: 32975918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout mice.
    Chen X; Zhang H; McAfee S; Zhang C
    Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H605-12. PubMed ID: 20581092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.
    Schneider M; Witztum JL; Young SG; Ludwig EH; Miller ER; Tsimikas S; Curtiss LK; Marcovina SM; Taylor JM; Lawn RM; Innerarity TL; Pitas RE
    J Lipid Res; 2005 Apr; 46(4):769-78. PubMed ID: 15654123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress.
    Galle J; Schneider R; Winner B; Lehmann-Bodem C; Schinzel R; Münch G; Conzelmann E; Wanner C
    Atherosclerosis; 1998 May; 138(1):65-77. PubMed ID: 9678772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation.
    Galle J; Lehmann-Bodem C; Hübner U; Heinloth A; Wanner C
    Nephrol Dial Transplant; 2000 Mar; 15(3):339-46. PubMed ID: 10692519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation.
    Schachinger V; Halle M; Minners J; Berg A; Zeiher AM
    J Am Coll Cardiol; 1997 Oct; 30(4):927-34. PubMed ID: 9316520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice.
    Mancini FP; Newland DL; Mooser V; Murata J; Marcovina S; Young SG; Hammer RE; Sanan DA; Hobbs HH
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1911-6. PubMed ID: 7583571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation.
    Doi H; Kugiyama K; Ohgushi M; Sugiyama S; Matsumura T; Ohta Y; Nakano T; Nakajima K; Yasue H
    Atherosclerosis; 1998 Apr; 137(2):341-9. PubMed ID: 9622277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a).
    Chiesa G; Hobbs HH; Koschinsky ML; Lawn RM; Maika SD; Hammer RE
    J Biol Chem; 1992 Dec; 267(34):24369-74. PubMed ID: 1280258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the interaction between mouse apolipoprotein B100 and apolipoprotein(a).
    Cheesman EJ; Sharp RJ; Zlot CH; Liu CY; Taylor S; Marcovina SM; Young SG; McCormick SP
    J Biol Chem; 2000 Sep; 275(36):28195-200. PubMed ID: 10837476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.